Fulcrum Therapeutics Inc (FULC)

Jan 19, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Purchased by Barclays PLC - Defense World

Jan 19, 2025

Jan 19, 2025

Barclays PLC Acquires 97,565 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Jan 19, 2025

Jan 13, 2025

Fulcrum Therapeutics Advances Pociredir for Sickle Cell Disease - TipRanks

Jan 13, 2025

Jan 12, 2025

Brokerages Set Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Price Target at $9.33 - Defense World

Jan 12, 2025

Jan 09, 2025

Analysts Set Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Price Target at $9.33 - MarketBeat

Jan 09, 2025

Jan 06, 2025

Suvretta Capital Management, LLC Acquires Additional Shares in F - GuruFocus.com

Jan 06, 2025

Jan 06, 2025

Geode Capital Management LLC Raises Stock Holdings in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Jan 06, 2025

Jan 04, 2025

Barclays PLC Boosts Holdings in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Jan 04, 2025

Dec 31, 2024

Stifel Financial Corp Decreases Stock Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Dec 31, 2024

Dec 30, 2024

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Short Interest Update - MarketBeat

Dec 30, 2024

Dec 29, 2024

State Street Corp Increases Holdings in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Dec 29, 2024

Dec 29, 2024

State Street Corp Boosts Stock Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Dec 29, 2024

Dec 27, 2024

FULC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fulcrum Therapeutics, Inc. and Encourages Investors to Contact the Firm! - The Eastern Progress Online

Dec 27, 2024

Dec 24, 2024

Fulcrum Therapeutics jumps amid takeover speculation - MSN

Dec 24, 2024

Dec 24, 2024

Fulcrum Therapeutics Receives Termination Notice from Sanofi Ending Collaboration Agreement for Losmapimod - Defense World

Dec 24, 2024

Dec 23, 2024

There's Reason For Concern Over Fulcrum Therapeutics, Inc.'s (NASDAQ:FULC) Massive 34% Price Jump - Simply Wall St

Dec 23, 2024

Dec 22, 2024

Fulcrum Therapeutics, Inc.(NasdaqGM:FULC) dropped from S&P Pharmaceuticals Select Industry Index - Marketscreener.com

Dec 22, 2024

Dec 19, 2024

Fulcrum Therapeutics (NASDAQ:FULC) shareholders have endured a 77% loss from investing in the stock three years ago - Yahoo Finance

Dec 19, 2024

Dec 18, 2024

Analysts Set Fulcrum Therapeutics, Inc. (NASDAQ:FULC) PT at $9.33 - Defense World

Dec 18, 2024

Dec 17, 2024

Charles Schwab Investment Management Inc. Acquires 393,202 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Dec 17, 2024

Dec 17, 2024

Charles Schwab Investment Management Inc. Has $2.03 Million Holdings in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World

Dec 17, 2024

Dec 16, 2024

Fulcrum Therapeutics' SWOT analysis: stock faces headwinds after trial setback - Investing.com

Dec 16, 2024

Dec 15, 2024

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Dec 15, 2024

Dec 13, 2024

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Stock Holdings Trimmed by Fmr LLC - MarketBeat

Dec 13, 2024

Dec 13, 2024

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Sold by Fmr LLC - Defense World

Dec 13, 2024

Dec 12, 2024

Fulcrum Therapeutics Insider Purchases Yet To Pay Off Regardless Of Recent Strength - Simply Wall St

Dec 12, 2024

Dec 10, 2024

Jacobs Levy Equity Management Inc. Takes $721,000 Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Dec 10, 2024

Dec 07, 2024

BlackRock, Inc. Reduces Stake in Fulcrum Therapeutics Inc. - GuruFocus.com

Dec 07, 2024

Dec 05, 2024

Fulcrum Therapeutics' SWOT analysis: stock faces challenges after trial setback - Investing.com Nigeria

Dec 05, 2024

Dec 05, 2024

RA Capital Management L.P. Sells 1,380,605 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Dec 05, 2024

Nov 30, 2024

Braidwell LP Acquires New Stake in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Nov 30, 2024

Nov 30, 2024

Connor Clark & Lunn Investment Management Ltd. Makes New $474,000 Investment in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Nov 30, 2024

Nov 29, 2024

Fulcrum Therapeutics (FULC) Upgraded to Buy: Here's Why - MSN

Nov 29, 2024

Nov 29, 2024

Suvretta Capital Management LLC Sells 1,358,255 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Nov 29, 2024

Nov 27, 2024

Fulcrum Therapeutics to Participate in Upcoming December Conferences - The Manila Times

Nov 27, 2024

Nov 26, 2024

Fulcrum Therapeutics to Present at Three Major Healthcare Conferences in December | FULC Stock News - StockTitan

Nov 26, 2024

Nov 21, 2024

CAMP4 Therapeutics Corporation (CAMP) reports earnings - Quartz

Nov 21, 2024

Nov 19, 2024

Facioscapulohumeral Muscular Dystrophy Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Fulcrum Therapeutics, aTyr Pharma, Fulcrum Therapeutics, Hoffmann-La Roche - The Globe and Mail

Nov 19, 2024

Nov 19, 2024

Fulcrum Therapeutics stock hits 52-week low at $2.87 By Investing.com - Investing.com Canada

Nov 19, 2024

Nov 19, 2024

Fulcrum Therapeutics stock hits 52-week low at $2.87 - Investing.com

Nov 19, 2024